An advance market commitment is a pre-negotiated purchase guarantee that kicks in when a supplier delivers a product meeting agreed technical and regulatory standards.

How it works

Donors or governments aggregate demand: “We will buy up to X units at $Y per unit if you achieve Z efficacy.” Developers use the commitment in fundraising, factory planning, and regulatory pathways. The COVAX-era vaccine AMC is the best-known example; similar structures appear for malaria products and some clean-tech offtake discussions.

Terms specify volume caps, price tiers, eligibility countries, and failure modes if specs are not met. AMCs differ from vanilla preorders because they often involve multilateral backing and public-health or strategic goals, not just one corporate customer.

Why it matters

• Founders: An AMC can substitute for early commercial revenue in investor decks— but diligence will scrutinize whether your product can actually hit specs on time.
• Investors: AMC-backed deals still carry technical risk; the commitment addresses demand risk, not clinical or engineering failure.
• GPs: Global health and climate funds track AMC pipelines for portfolio construction.

Common mistake

Equating a non-binding letter of interest with an AMC. Without enforceable purchase terms and funded backers, banks and VCs will not treat it as secured demand.

Related ideas

Offtake agreements, additionality in public finance, procurement guarantees, and biotech milestone funding.